Kathleen M. Darcy, PhD
Chief Operations Officer
Gynecologic Cancer Center of Excellence
3289 Woodburn Rd
Suite 370
Annandale,
VA
USA
22003
Papers:
43 - Featured Poster
Identification of candidate circulating cisplatin resistance biomarkers from epithelial ovarian carcinoma cell secretomes
49 - Featured Poster
Pathogenesis of ARID1A-driven gynecologic cancer
98 - Featured Poster
Phase I trial results of a folate receptor alpha-directed cancer vaccine (E39) in ovarian and endometrial cancer patients to prevent recurrence
282 - Poster Session A
Ovarian cancers with nuclear special AT-rich sequence-binding protein 1 and cytoplasmic AT-rich interactive domain-containing protein 1A are rare, drug-resistant, and deadly
295 - Poster Session A
Curated Ovarian Database-derived identification of genes predicting survival in primary serous epithelial ovarian cancer
306 - Poster Session A
Pharmacologic inhibition of polo-like kinase 1 enhances paclitaxel-based cell killing in taxol-resistant ovarian cancer cells
337 - Poster Session A
Proteomics of endometrial carcinogenesis: identification of candidates underlying disease pathogenesis
525 - Poster Session B
Correlation of survival-stratified proteomic and curated gene data reveal a three protein biomarker panel that predicts long-term survival of patients with primary epithelial ovarian cancer
526 - Poster Session B
Diminished survival of separated, divorced, or widowed uterine cancer patients: a potential focus for survivorship programs